Levomilnacipran ameliorates lipopolysaccharide-induced depression-like behaviors and suppressed the TLR4/Ras signaling pathway.

Autor: Li S; Department of Physiology, Shandong University, School of Basic Medical Sciences, Cheeloo College of Medicine, 44 Wenhuaxilu Road, Jinan, Shandong Province 250012, PR China., Zhu Z; Department of Physiology, Shandong University, School of Basic Medical Sciences, Cheeloo College of Medicine, 44 Wenhuaxilu Road, Jinan, Shandong Province 250012, PR China., Lan T; Department of Physiology, Shandong University, School of Basic Medical Sciences, Cheeloo College of Medicine, 44 Wenhuaxilu Road, Jinan, Shandong Province 250012, PR China., Wu Y; Department of Physiology, Shandong University, School of Basic Medical Sciences, Cheeloo College of Medicine, 44 Wenhuaxilu Road, Jinan, Shandong Province 250012, PR China., Li Y; Department of Physiology, Shandong University, School of Basic Medical Sciences, Cheeloo College of Medicine, 44 Wenhuaxilu Road, Jinan, Shandong Province 250012, PR China., Wang C; Department of Physiology, Shandong University, School of Basic Medical Sciences, Cheeloo College of Medicine, 44 Wenhuaxilu Road, Jinan, Shandong Province 250012, PR China., Jian W; Department of Radiology, Qilu Hospital of Shandong University, 107 Wenhuaxilu Road, Jinan, Shandong Province 250012, PR China. Electronic address: jianwencheng@hotmail.com., Yu SY; Department of Physiology, Shandong University, School of Basic Medical Sciences, Cheeloo College of Medicine, 44 Wenhuaxilu Road, Jinan, Shandong Province 250012, PR China; Shandong Provincial Key Laboratory of Mental Disorders, School of Basic Medical Sciences, 44 Wenhuaxilu Road, Jinan, Shandong Province 250012, PR China. Electronic address: shuyanyu@sdu.edu.cn.

Publikováno v: International immunopharmacology [Int Immunopharmacol] 2023 Sep; Vol. 122, pp. 110595. Date of Electronic Publication: 2023 Jul 04.

Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant.

Autor: Atsou K; Lundbeck SAS, Issy-les-Moulineaux , Paris, France., Ereshefsky L; Follow the Molecule: CNS Consulting LLC , Marina del Rey, CA, USA.; The University of Texas , San Antonio, TX, USA., Brignone M; Lundbeck SAS, Issy-les-Moulineaux , Paris, France., Danchenko N; Lundbeck SAS, Issy-les-Moulineaux , Paris, France., Diamand F; Lundbeck SAS, Issy-les-Moulineaux , Paris, France., Mucha L; Takeda Pharmaceuticals , Deerfield, IL, USA., Touya M; Lundbeck , Deerfield, IL, USA., Becker R; Russell Becker Consulting , Chicago, IL, USA., François C; Lundbeck , Deerfield, IL, USA.

Publikováno v: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2021 Feb; Vol. 21 (1), pp. 29-42. Date of Electronic Publication: 2021 Jan 17.

Measures of suicidality in phase 3 clinical trials of levomilnacipran ER in adults with major depressive disorder.

Autor: Thase ME; 1Department of Psychiatry,Perelman School of Medicine,University of Pennsylvania,Philadelphia,Pennsylvania,USA., Gommoll C; 2Allergan,Jersey City,New Jersey,USA., Chen C; 2Allergan,Jersey City,New Jersey,USA., Kramer K; 2Allergan,Jersey City,New Jersey,USA., Khan A; 3Northwest Clinical Research Center,Bellevue,Washington,USA., Durgam S; 2Allergan,Jersey City,New Jersey,USA.

Publikováno v: CNS spectrums [CNS Spectr] 2017 Dec; Vol. 22 (6), pp. 475-483. Date of Electronic Publication: 2017 May 19.

Cortical thickness increases with levomilnacipran treatment in a pilot randomised double-blind placebo-controlled trial in late-life depression.

Autor: Krause-Sorio B; Department of Psychiatry, Semel Institute for Neuroscience, University of California Los Angeles, Los Angeles, California, USA., Kilpatrick L; Department of Psychiatry, Semel Institute for Neuroscience, University of California Los Angeles, Los Angeles, California, USA., Siddarth P; Department of Psychiatry, Semel Institute for Neuroscience, University of California Los Angeles, Los Angeles, California, USA., Ercoli L; Department of Psychiatry, Semel Institute for Neuroscience, University of California Los Angeles, Los Angeles, California, USA., Laird KT; Department of Psychiatry, Semel Institute for Neuroscience, University of California Los Angeles, Los Angeles, California, USA., Aguilar-Faustino Y; Department of Psychiatry, Semel Institute for Neuroscience, University of California Los Angeles, Los Angeles, California, USA., Milillo MM; Department of Psychiatry, Semel Institute for Neuroscience, University of California Los Angeles, Los Angeles, California, USA., Narr KL; Department of Psychiatry, Semel Institute for Neuroscience, University of California Los Angeles, Los Angeles, California, USA.; Department of Neurology, University of California Los Angeles, Los Angeles, California, USA., Lavretsky H; Department of Psychiatry, Semel Institute for Neuroscience, University of California Los Angeles, Los Angeles, California, USA.

Publikováno v: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2020 Mar; Vol. 20 (2), pp. 140-148. Date of Electronic Publication: 2019 Jul 22.

About the Misleading Use of Stereodescriptors in Labeling the Stereoisomers of Milnacipran and Levomilnacipran.

Autor: Baumann P; Département de Psychiatrie (DP-CHUV), Université de Lausanne, Prilly-Lausanne, Switzerland pierre.baumann@chuv.ch.

Publikováno v: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2019 Nov/Dec; Vol. 39 (6), pp. 673-674.